Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Infant Formula Safety Questions Don’t Include Cronobacter National Reportable Disease Listing

Nov 18 2022

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA Plans Streamlining Infant Formula Approval Process To Expand Supply Chain

Jul 07 2022

USDA Examines Potential Production Regulation Changes To Prevent Powder Formula Contamination

Oct 25 2022

Additional Topics

International United States US States Dietary Supplements Supply Chain FDA Enforcement Advertising, Marketing & Sales Business Strategies Companies Commercial Consumer Compliance Distribution Guidance Documents Ingredients Manufacturing Policy Regulation Retail Safety

More from Supply Chain

More from HBW Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.